Sunday, March 9 2014 8:35 PM EDT2014-03-10 00:35:58 GMT
LOUISVILLE, Ky. (WDRB) --- Louisville head football coach Bobby Petrino held a news conference before the Louisville-UConn men's basketball game Saturday to preview the start of spring football. The CardinalsMore >>
Petrino talked quarterback competition and the arrest of an incoming freshman, among other topics...More >>
Follow the WDRB Newsroom, Reporters and Anchors.More >>
Tweets from the WDRB Newsroom, Reporters and Anchors.More >>
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
NEW YORK, Dec. 31, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.
The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market.
The estimated value of the market was calculated based on the materials, (industry) products, and applications revenue. Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on industry, the market is classified into pharmaceutical, in-vitro diagnostics, and drug delivery devices. The pharmaceutical segment is categorized into microfluidics chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The microfluidics chips for lab analytics segment is further classified into toxicity screening, proteomic analysis, gene sequencing, and capillary electrophoresis. In-vitro diagnostics is further segmented into clinical diagnostics, Point-of-Care diagnostics, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.
Based on applications, the market is categorized into six applications, namely, drug delivery, industrial and environmental, analytical devices, pharmaceutical and life science research, Point-of-Care diagnostics, and clinical and veterinary diagnostics. The Point-of-Care diagnostics segment commands the largest share of the global applications market. It is expected to grow at a strong CAGR during the study period. The large share of this segment is attributed to the increased adoption of microfluidics in Point-of-Care diagnostics by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.).
North America dominates the market, accounting for around one-third of the share. The leading market share of the North American region is attributed to the presence of a large number of major manufacturers such as, Abbott Laboratories, Agilent Technologies, Caliper Life Sciences (PerkinElmer), and Johnson & Johnson, in this region. Additionally, the rising adoption of microfluidics technology and the increasing rate of new product launches in the North American region are the favorable factors driving the market growth.
Global Microfluidics Market Scenario
Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21 1.2 REPORT DESCRIPTION 21 1.3 MARKETS COVERED 23 1.4 STAKEHOLDERS 24 1.5 MARKET SCOPE 25 1.6 RESEARCH METHODOLOGY 26 1.6.1 MARKET SIZE ESTIMATION 27 1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 28 1.6.3 KEY DATA POINTS FROM PRIMARY SOURCES 31 1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 32 1.6.5 ASSUMPTIONS 33
2 EXECUTIVE SUMMARY 34
3 PREMIUM INSIGHTS 37
3.1 GLOBAL MICROFLUIDICS MARKET, A SNAPSHOT (2013) 37 3.2 MARKET DYNAMICS 38 3.3 MICROFLUIDICS MARKET, BY INDUSTRY 39 3.4 MICROFLUIDICS MARKET, BY APPLICATIONS 40 3.5 GEOGRAPHIC ANALYSIS & MATERIALS MARKET 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 43 4.2 MARKET SEGMENTATION 44 4.3 MARKET DYNAMICS 46 4.3.1 DRIVERS 46 184.108.40.206 Rising demand for Point-of-Care (POC) testing to drive the market 46 220.127.116.11 Quick return on investments helping in cost reductions 46 18.104.22.168 Microfluidic chips miniaturization helps to reduce testing time and cost 46 4.3.2 RESTRAINTS 47 22.214.171.124 The incorporation of emerging microfluidic technology into existing workflows is challenging 47 126.96.36.199 Complex and time consuming regulatory standards to lengthen the approval process 47 4.3.3 OPPORTUNITIES 48 188.8.131.52 Growing Asian market 48 184.108.40.206 Shifting trend towards polymers adoption 48 220.127.116.11 Expanding applications of drug delivery technologies 49 4.3.4 TRENDS 49 18.104.22.168 Increasing number of patent applications 49 4.3.5 CHALLENGES FOR MANUFACTURERS 50 22.214.171.124 Geometrical issues 50 126.96.36.199 Surface chemistry issues 50 4.3.6 WINNING IMPERATIVES 51 188.8.131.52 Standardization 51 184.108.40.206 Compatibility 51 4.4 STRATEGIC BENCHMARKING 52 4.4.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT 53 220.127.116.11 Collaboration between Fluidigm Corporation and Olink Bioscience 53 18.104.22.168 Agreement between Agilent Technologies, Inc. and Caliper Life Sciences, Inc. 53 22.214.171.124 Agreement between PerkinElmer and GenMark Diagnostics, Inc. 53 126.96.36.199 Collaboration between Roche Diagnostics and Immatics Biotechnologies GmbH 54 188.8.131.52 Agreement between RainDance Technologies and Myriad Genetics, Inc. 54